A versatile
biomarker for detecting colonic
adenoma and
colon cancer has yet to be developed.
Colon cancer secreted protein-2 (CCSP-2) is a
protein specifically expressed and secreted in colon
adenomas and
cancers. We developed a fluorescent imaging method based on CCSP-2 targeting for a more sensitive and specific detection of
colorectal tumors. CCSP-2 expression was evaluated in human colon
adenoma and colorectal specimens. Anti-CCSP-2 antibody was labeled with a near-infrared
fluorescent dye, FPR-675, and molecular imaging of surgical human
colorectal tumors was performed. Immunohistochemistry identified CCSP-2 expression in 87.0% of
colorectal cancer specimens and 89.5% of colon
adenoma specimens. Fluorescence imaging of surgical human colon specimens after spraying treatment with the probe permitted a clear distinction of
cancer from paired normal colon tissue (target-to-background ratio, 4.09±0.42; P<.001). CCSP-2 targeting imaging was also evaluated in patient-derived
colon cancer xenograft mouse and liver
metastasis murine models. CCSP-2-positive
colon cancer xenografts and liver
metastases were visualized by near-infrared fluorescence imaging after
intravenous injection of the probe, which showed significantly higher fluorescence. Our results show that CCSP-2 is a promising marker for
colorectal tumor detection in clinical settings and that a CCSP-2-targeting molecular imaging strategy might improve the diagnosis of
colorectal tumors in metastatic or recurrent
cancers and aid in early colonoscopic detection of premalignant lesions.